Tag: Drugs: Misc.
FDA Issues Emergency Use Authorization for Remdesivir
Remdesivir can be administered intravenously to treat COVID-19 patients with severe disease
Remdesivir May Accelerate Recovery From Severe COVID-19
Early results from NIH study promising, but Lancet study did not show significant clinical benefit
Diabetes Medication Prescribing Increased 2003 to 2016
However, authors say there is little evidence that doctors are tailoring treatment for patients
March 2020 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for March 2020. This roundup includes the latest...
February 2020 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for February 2020. This roundup includes the latest...
January 2020 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for January 2020. This roundup includes the latest...
Benefits of Psilocybin-Assisted Psychotherapy May Be Lasting
Reductions in anxiety, depression in cancer-related psychiatric distress sustained at 3.2 and 4.5 years
December 2019 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for December 2019. This roundup includes the latest...
November 2019 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for November 2019. This roundup includes the latest...
October 2019 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for October 2019. This roundup includes the latest...
